chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I woke up Wednesday morning with a raging sore throat. During the day, the sore throat dissipated, and I took my temperature and had no fever. I got up at 3:30 AM, Thursday, 12/22/2022. I had a slight sore throat and a runny nose, but I had no fever. I got on an airplane at 6:30 AM for a domestic flight. My daughter picked me up at the airport. I told her I had had a slight sore throat. We went to her house, and she immediately tested me for COVID-19. I was positive for COVID-19. I then immediately made reservations to return home and flew back home several hours later. I then went to bed at 8 PM and stayed in bed for most of the day during the following two to three days. I then started getting better. On 12/23/2022, I called a phone number and spoke to a NP to see if I could get PAXLOVID, but she told me she could not prescribe it to me, as I was on PLAVIX. I treated my symptoms with MUCINEX, TYLENOL and cold medicine and got better. I took a home antigen test on 12/22/2022, 12/25/2022, 12/28/2022, 1/2/2023, and 1/4/2023. With the exception of the one I took on 1/4/2023, I tested positive on all of them.
Initial unsolicited report received from a consumer on 26 May 2016. Manufacturer control number: 2016268325. This case involves a female patient who was vaccinated with a dose of TETANUS TOXOID (batch number, expiration date, dose, dose number, route and site of administration were not reported) on an unspecified date. The patient's medical history and concomitant medication were not reported. Patient's previous medication included TETANUS TOXOID which she took probably 3-4 years ago. On unspecified date following the vaccination, the patient experienced fever and the injection site was very inflamed. Laboratory data and corrective treatment were not reported. The patient's outcome was not reported. Documents held by sender: none.
Induration, erythema & tenderness on the site of Td shot 7 days p/injection;
Record shows patient had J&J on 03/28/21, Moderna full dose on 11/01/2021 and received Moderna full dose on 12/19/2021. Patient claimed she never had COVID vaccine before.
Pt stated that in the middle of the night (14th), her arm became very painful and tender, to the point that it woke her up. Proceeded to be very tender to the touch and decreased ROM all day of the 15th. Reports large irregular redness pattern on arm. Denies tingling and numbness. Returned to office on 03/16 with continuing sx. Diagnosed with cellulitis. Given cephalexin (500 mg BID) and instructed to inform us if sx worsen or do not improve.
bp 128/76  pt w syncope 5 mins into monitoring. hit head on front left. monitored  for s/sx of  concussion. denies blurred vision head ache. monitored for 15mins post fall 09:07 am pt c/o blurring in right eye peripheral vision  pt to check with pcp if symptoms continue or worsen.
The injection site is red and swollen. The swelling has moved around the front of my forearm and into my inner arm towards my armpit with bruising around the swelling. From pictures I've seen online, it resembles COVID arm.
fever; chills; muscle aches; left arm red; left arm swollen; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (fever), CHILLS (chills), MYALGIA (muscle aches), ERYTHEMA (left arm red) and PERIPHERAL SWELLING (left arm swollen) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037KZOA) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historic conditions for the patient.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), CHILLS (chills), MYALGIA (muscle aches), ERYTHEMA (left arm red) and PERIPHERAL SWELLING (left arm swollen). At the time of the report, PYREXIA (fever), CHILLS (chills), MYALGIA (muscle aches), ERYTHEMA (left arm red) and PERIPHERAL SWELLING (left arm swollen) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Approximately 24 hours after dose #2, I noticed and felt "COVID arm"--a round, red spot near my injection site that hurt to touch and was red. Several days later, it began to itch. Nearly six days after that, or on the 7th day following my vaccination, I woke to extreme itching. I didn't think much about it and had a busy day but was constantly itching. That afternoon, I noticed hives all over my body. Places that I had scratched or that touched clothing, such as my waistline, undergarment lines, behind my ears (mask), knees, etc had spread and become angrier. These places have become welt-like, often coming together. I have no known allergies and have not eaten anything unusual. I've also never had hives. This second day covered in hives has been extremely itchy at times, but Benadryl and Cortizone 10--at least in spots not constrained by clothing--have provided some relief.
Site: Pain at Injection Site-Medium, Additional Details: Patient stated that he had pain with the arm where the injection was given. He said he feels the pain when he does some kind of work with it and at one point had some difficulty lifting the arm. He said he never tried taking any otc pain medication. I suggested he try that first. If he still has any pain, he should contact his regular dr.
WITHIN 7 MINUTES, DEVELOPED LIGHTHEADEDNESS WHILE SITTING AND STANDING, THAT LASTED UNTIL 12PM ON 1/5/21.
She has urinary tract infection; This is a spontaneous report from a contactable consumer or other non hcp.   A female patient of an unspecified age received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation; ciprofloxacin (CIPRO [CIPROFLOXACIN]), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at UNK, 2x/day for urinary tract infection. The patient medical history and concomitant medications were not reported. It was reported that, she was scheduled to get her third dose on Thursday however she just filled the prescription Cipro, she had urinary tract infection or UTI (unspecified vaccine) actually she also has additional medical inquiry if she will be taking instead of taking booster shot if she will be having the medicines and she is on infection.So, already informed her that the Pfizer Medical Information will be open tomorrow and already provided the number.The outcome of the event urinary tract infection on an unspecified date with outcome of unknown. Therapeutic measures were taken as a result of she has urinary tract infection (urinary tract infection).  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  Follow-up (21Oct2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Case completed primary 2 dose series, and  booster for Covid by August 2021, then was hospitalized for Covid in January 2022 Hospitalized at:  local Hospital.   COVID-19 Assessment & Plan Patient had mild symptom onset on 1/17 followed by worsening symptoms and positive test on on 1/19 and has had progressive symptoms since that time. She had a second positive home antigen test on 1/29. Has dyspnea, cough, nausea, diarrhea, and fatigue. Fully vaccinated with booster - Decadron 6 mg daily, currently on day 6 of a 10-day course which she will finish at home. Completed 5 days of remdesivir - No role for systemic abx, briefly started on admission but quickly stopped with no evidence of bacterial infection -Completed isolation - Full code
Mild pain at injection site and runny nose/sneezing day after vaccine; Mild pain at injection site and runny nose/sneezing day after vaccine; Mild pain at injection site and runny nose/sneezing day after vaccine; This is a spontaneous report from a contactable pharmacist (patient herself). A 30-year-old female patient received her first dose of bnt162b2 (BNT162B2 also reported as COVID 19 brand Pfizer, lot Ej1685), via an unspecified route of administration in the left arm on 21Dec2020 12:00 at single dose for Covid-19 immunisation. Medical history included allergy to PCN (rash to PCN as a child). No other vaccine in four weeks prior to Covid-19 vaccine. No Covid-19 prior to vaccination. The patient's concomitant medications were not reported. The patient experienced mild pain at injection site and runny nose/sneezing day after vaccine (22Dec2020). No treatment was given to the patient. The outcome of events was recovered.
Based on addition information received on 04 May 2015, this case became medically confirmed. Initial unsolicited report received from a Consumer (Patient parent) on 19 September 2014. A 19-year-old female patient, had received an intramuscular first dose of IMOVAX vaccine (lot number: K1729-1, expiry date- 07 Dec 2016) in right deltoid on 14 Jan 2015 and had received an intramuscular second dose of IMOVAX vaccine (lot number: K1729-1, expiry date- 07 Dec 2016) in right deltoid on 22 Jan 2015. The patient had no illness at the time of vaccination. The patient had no pre-existing physician diagnosed allergies, birth defects, medical conditions. It was reported that patient had experienced similar event at the age of 17 when she had to take percocet after an orthopedic procedure. Patient had the anger, sadness, and experienced hallucinations after the. On 14 Jan 2015 and 22 Jan 2015 i.e. 24 Hour after each vaccination patient had significant mood change. Patient becomes angry, doesn't feel like she was in control, was clearly frustrated, but has not acted out. Patient had also deep feeling of sadness. Corrective treatment was not reported and no laboratory details. On an unspecified date patient was recovered. Documents held by sender: None. Follow up information received from the healthcare professional (medical notes provided) on 04 May 2015. It was reported that patient had received third dose of Rabies vaccine (Batch number- K1729-1, expiry date- 07 December 2016) on 06 February 2015 in left deltoid. The patient was allergic to salmon- throat swelling, and difficulty (fish allergy) and history of pilonidal cyst removal 2010, knee surgery NOS (3 year ago). Social history: patient denied smoking, drug use and alcohol use. Family history: patient's father died at the age of 58, due to blood cancer. It was reported that the patient was not on any medication. On 06 February 2015 patients vitals were blood pressure 105/67 mmhg, pulse 71bpm, RESP(respiration)-14 breath/min, temperature 97.6 BMI-24.021, LMP-09 January 2015 and oxygen saturation at 11:17:00 was 97%. On 14 January 2015 patients vitals were blood pressure 111/68 mmhg, pulse 81bpm, RESP (respiration)-14 breath/min, temperature 97.6, BMI-24.021 and oxygen saturation at 11:17:00 was 95%. On 21 January 2015 patients vitals were blood pressure 99/69 mmhg, pulse 68bpm, RESP (respiration)-14 breath/min, temperature 96.9, BMI-24.021 and oxygen saturation at 11:17:00 was 95%. Last menstrual period was reported as 09 January 2015 and estimated date of delivery was not reported. Hence, an event of vaccine exposure during pregnancy coded as patient was exposed to vaccine during first trimester. Pregnancy outcome not reported. Documents held by sender: none.
Asthma attack - I took 2 puffs of the Xopenex inhaler every 4 hours for 12 hours. I also took the 12 hour Dulera inhaler and I took muncinex 600 mg.
PFIZER-BIONTECH COVID-19 EUA. PATIENT FULLY VACCINATED WITH PFIZER COVID-19 VACCINE.    7/19/21 4:19PM: TESTED POSTIVE FOR COVID-19. COUGH WITH CONGESTION NOTED. 02 SAT 97%.     7/20/21 10:57AM: O2 SAT 98%, AFEBRILE. NO COMPLAINTS.  7/20/21 8:30PM: PATIENT 02 sat 77% RA, SOB, non-prod cough, wheezes/crackles TO LUNG FIELDS. PLACED ON O2 @4L, O2 CAME UP TO 82%. PATIENT VERY LETHARGIC. AFEBRILE AT 98.4. NURSING FACILITY SENT TO ER.
I seem to have thrown a clot that blocked Right Optic Nerve Artery. Immediate blindness in Right Eye.
Extreme pain Hallucinating Psychogenic non epileptic seizures Temporary blindness Muscle tensing
On 8/20 I experienced an intense head rush while sitting watching TV. I felt faint and laid down. Lightheadedness has persisted until today. I experienced a minor headache afterwards. That night at midnight I experienced chest pain, temporarily paralysis, palpitations, and tingling in the extremities. I was taken to the ER and diagnosed with atypical migraines. I was prescribed prochlorperazine. Extreme anxiety and brain fog persisted for about 3 weeks. On 9/5 I became sensitive to light. That night I became nauseous and vomited. On 9/6 I had blurry vision.  On 9/7 I blacked out at work; coworkers laid me down. I became nauseous. For about 1 week I was sluggish, fatigued, and weak. I experienced loss of appetite and lost about 8 lbs. I suffered from insomnia. I also had diarrhea, constipation, and back pain. I went to urgent care 9/12 with no treatment plan. I followed up with my pcp 9/15 with instructions to schedule a holter monitor and echocardiogram. I followed up with neurology 9/21. The doctor prescribed me anxiety medication which I have not taken as the anxiety has resolved. I wore a 24-hour heart monitor 9/23-9/24. I followed up with my pcp again 9/23. I was to follow up with cardiology and neurology again which I have to schedule. The night of 9/27 I experienced extreme chest pain on my left side - a sharp, stabbing, pressure feeling - that radiated to my left arm, left back, left shoulder, and left neck. My pcp instructed me to go to the heart hospital; I went the afternoon of 9/28. The doctor prescribed me naproxen for suspected pericarditis. The naproxen has eased the pain, however, I am still very limited in my activity. I cannot exert myself very long; I am confined to lying down most of the day or I grow very lightheaded, dizzy, weak, and pale. Headaches have persisted over this course of time ranging from mild to severe.
Employee received influenza vaccine at ~1340 on 09-21-2018. Returned to work location and began to experience sudden headache, diaphoresis, and nausea. No shortness of breath. Escorted to the ED.
This spontaneous report was received from an office manager concerning an unspecified patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with an improperly stored dose of GARDASIL 9 (strength, dose, route, lot number and expiration date were not reported) for prophylaxis. The temperature of excursion was detected by a data logger. No adverse effects were reported. This is one of several cases from the same reporter. Sender's Comments: US-009507513-1709USA009964: US-009507513-1709USA010096.
Patient developed cellulitis in (L) arm and breast after receiving injection on 11/8/15.
12/12/05 BP today at 160/98 Pulse 98bpm.  Cient presents today with c/o adverse reaction from influenza vaccine she received on 12/5/05 at our office.  Noted area to left deltoid at ~2" x 3/4" with faint yellowish-green area appearing to be old bruise.  Client states that within 30 minutes after receiving flu shot, she became symptomatic with dizziness, heart palpitations, swollen tongue, whelps to tongue, and nausea.  States later in day developed loose stools that persisted for ~1 week.  Discussed VIS information including recommendations to follow-up with PCP for such symptoms.  Client voiced understanding.  States she feels it was a reaction to the vaccine and nothing else was different in her daily routine, intake, or encounters to cause a reaction except this vaccine.  States symptoms persist today including occasional palpitations, dizziness, occasional nausea, and sweating.  Discussed increased pulse and BP findings and encouraged follow-up with PCP immediately for evaluation.  Client voiced understanding.  Plans to seek medical care today with PCP.  Discussed need to avoid flu vaccine in future until allergic reaction ruled out by PCP.   Client states at onset of symptoms after shot received, she took P.O. Benadryl with relief of swelling.  Has not taken any other medication or done any further interventions for tx since 12/5/05.   12/16/05  T.C. to client.  States she went for appt with NP and was told that it would be greater than 1 week before appt date so she decided to go home and see if symptoms stopped.  States she is no longer experiencing problems and does not plan further follow-up.  States she will no longer take flu shot in future. Questions encouraged.
Caller states he took his first Moderna vaccine yesterday at 1:00 PM.  The vaccine was given in his left arm, however, approx. 3 hours later, he noted swelling and  skin discoloration of  fingers of his right hand.  Encourage the caller to seek medial care for an evaluation of his right hand.
lower back/pelvis pain, fever 103 with Tylenol and ibrophen, rigors, fatigue, nausea
On 9-5-2016 he developed slight temp highest was 101.9 on 9-7-2016.On 9-8-16 he had fine red rash mainly on trunk. Rash went away until 9-15-16 when bright red rash returned and covers entire body. Appetite decreased. No Temp.
pt recvd vax; exp a sz which lasted 3-4 mins;seen by MD;
Bell's Palsy - right side; This is a spontaneous report from a contactable consumer (Patient). A 47-year-old male patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0151), dose 2 via an unspecified route of administration in the left arm on 13Apr2021 as dose 2, single for covid-19 immunisation. The patient previously received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration in the left arm on 23Mar2021 as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not covid tested post vaccination. Patient was covid prior to vaccination. On 26Jul2021 at 21:00, the patient experienced bell's palsy - right side. Therapeutic measures were taken as a result of bell's palsy - right side. Patient received treatment of Antiviral and steroid. The outcome of the events was not recovered.
Headache, visual disturbances, double vision, went to the ED and had MRI showing the cerebral venous clot and I was on a heparin drip for 5 days before transitioning to oral Coumadin; 3 weeks later changed to Eliquis for 6 months
Information has been received from a physician concerning a patient who on 25-MAR-2008 was vaccinated with the first dose of oral ROTATEQ (lot # reported as 1398U).  On 21-MAY-2008, the patient received the second dose of oral ROTATEQ (lot # 660425/0278X). On 06-OCT-2008 the patient was admitted to the hospital for two days for rotavirus.  Rotavirus testing came back positive for rotavirus.  The patient was given IV fluids and the symptom has resolved.  The recovered date is unknown.  No product quality complaint involved.  Additional information has been requested.
Second dose of Monovalent Covid Vaccine was administered on 4/20 after the deauthorization was made.
On 7/28/09, second dose of Hepatitis A was given to pregnant pt. Denies allergies or medical history. Patient chart did not accompany her and pt didn't report she was pregnant. At time of injection, pt was 19 weeks EGA. No fetal harm reported to date.
3rd dose administered; 2nd dose given on 09Jan2021, third dose given on 29Jan2021; vaccine leaking out; This is a spontaneous report received from a contactable reporter(s) (Other HCP).  A 37 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 29Jan2021 (Lot number: EL9261, Expiration Date: May2021) at the age of 37 years as dose 3 (booster), 0.3 ml single for covid-19 immunisation. Relevant medical history included autoimmune disorder (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included Bnt162b2 (Dose 1, 0.3 ml, single, Lot number: EJ1685, Expiration date: Mar2021, Route of administration: Intramuscular), administration date: 18Dec2020, when the patient was 37 years old, for COVID-19 immunisation; Bnt162b2 (Dose 2, 0.3 ml, single, Lot number: EK9231, Expiration date: Apr2021, Route of administration: Intramuscular), administration date: 09Jan2021, when the patient was 37 years old, for COVID-19 immunisation. The following information was reported IMMUNISATION (non-serious) with onset 29Jan2021, outcome unknown; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 29Jan2021, outcome unknown; VACCINATION SITE EXTRAVASATION (non-serious) with onset 29Jan2021, outcome unknown. Therapeutic measures were not taken as a result of vaccination site extravasation. Upset due to vaccine leaking out, administered by student nurse. No Z-Track method and/or sensation of skin preparation evaporation.  No follow-up attempts are possible. No further information is expected.
ACHES, COUGH, NAUSEA, DECREASED APPETITE, HEADACHE AND SORE THROAT
URTICARIA, SWOLLEN LEFT THIGH 5 DAYS AFTER GETIING MMR & VARICELLA VACCINATION IN HIS LEFT THIGH
Narrative:  85 year old male, received first dose of COVID-19 vaccine (Pfizer) on 5/10/2021. PMH of severe COPD, dependent on oxygen. Patient expired 5/17/2021.
This spontaneous report as received from a physician via field representative referred to a 40 year old female patient. The patient's medical history included severe chicken pox outbreak as a child. On 02-MAR-2013 the patient was vaccinated with ZOSTAVAX (1 injection, lot#, dose/frequency were unspecified). A few days after injection in March 2013 the patient developed in a 3-4 inch around the injection site with vesicular moist lesions that were painful. It had since spread to her neck and chin. Physician reported that he did not administer the injection. The injection was administered at pharmacy. Physician believes that the injection was not given in the deltoid region, that it was in fact given in the mid triceps area. Patient had sought medical attention via speaking with physician. No lab diagnostics studies were performed. BENADRYL (manufacturer unspecified) and VALTREX (manufacturer unspecified) were given as treatment for the events. The outcome was reported as not recovered. The causality was not provided. Additional information has been requested.
Narrative:  Per 1/11/22 note: Influenza vaccine is contraindicated: Severe allergic reaction (e.g. anaphylaxis) to a vaccine component Comment: Patient stated that she had ANAPHYLAXIS REACTION to the flu vaccine This reaction occurred at another clinic. No other documentation available.
Myalgia, Fever, fatigue Narrative:  Per nursing report: "c/o received 2nd Moderna vaccine on yesterday January 25th. C/o low grade fever, achy, no energy and extreme sore right arm. States fever last night at 6pm was 100.0."
This spontaneous report as received from a healthcare worker refers to two elderly patients. The patients had unspecified "adverse effect" after the use of PNEUMOVAX23 (Lot#, dose/frequency, route and duration were unspecified) on an unknown date. At the time of reporting the outcome of unspecified adverse effect was unknown. Additional information has been requested.